序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值(亿元)
|
归母净利润同比增长(06-30)
|
归母净利润同比增长(03-31)
|
营业收入同比增长(06-30)
|
营业收入同比增长(03-31)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 603456.SH | 九洲药业 | 2023-07-06 | — | — | 医疗研发外包 | 18.68 | 27.41 | 25.29 | 1.95 | 2.65% | 166.15 | 10.70% | 5.68% | 3.86% | 0.98% |
2 | 300363.SZ | 博腾股份 | 2014-02-12 | — | — | 医疗研发外包 | 25.58 | — | — | 2.64 | — | 139.53 | 115.91% | 95.48% | 19.88% | 18.21% |
3 | 301520.SZ | 万邦医药 | 2023-10-10 | — | — | 医疗研发外包 | 43.71 | 34.07 | 50.85 | 1.94 | 0.8% | 29.14 | -51.28% | -60.09% | -21.57% | -21.20% |
4 | 600721.SH | 百花医药 | 2008-01-25 | — | — | 医疗研发外包 | 10.01 | 92.8 | 86.89 | 4.89 | — | 38.49 | 12.46% | 0.28% | 2.95% | 6.65% |
5 | 300149.SZ | 睿智医药 | 2010-12-29 | — | — | 医疗研发外包 | 12.95 | — | — | 5.21 | — | 64.49 | 140.35% | 126.09% | 14.75% | 11.37% |
6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 医疗研发外包 | 7.94 | — | — | 3.35 | — | 51.53 | 7.74% | -41.04% | 6.01% | -11.29% |
7 | 301096.SZ | 百诚医药 | 2021-12-27 | — | — | 医疗研发外包 | 62.92 | — | — | 2.66 | — | 68.73 | -97.69% | -152.59% | -36.70% | -40.32% |
8 | 301201.SZ | 诚达药业 | 2022-01-27 | — | — | 医疗研发外包 | 27.48 | — | — | 2.0 | 0.71% | 42.52 | -49.06% | -107.51% | 11.24% | -24.37% |
9 | 301333.SZ | 诺思格 | 2022-08-09 | — | — | 医疗研发外包 | 56.45 | 38.88 | 38.17 | 2.89 | 0.28% | 54.52 | 4.45% | 13.12% | 0.18% | -2.53% |
10 | 301509.SZ | 金凯生科 | 2023-08-10 | — | — | 医疗研发外包 | 38.39 | 119.76 | 59.07 | 2.13 | 1.04% | 46.24 | 123.61% | 183.24% | 32.98% | 41.83% |
11 | 300347.SZ | 泰格医药 | 2012-08-24 | — | — | 医疗研发外包 | 61.22 | 130.11 | 178.3 | 2.57 | 0.49% | 527.12 | -22.22% | -29.61% | -3.21% | -5.79% |
12 | 688710.SH | 益诺思 | 2024-09-10 | — | — | 医疗研发外包 | 39.19 | 37.39 | 149.54 | 2.37 | — | 55.25 | -115.88% | -90.33% | -38.04% | -29.35% |
13 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 医疗研发外包 | 77.16 | — | — | 4.97 | — | 103.67 | 81.63% | 61.27% | 3.64% | 2.92% |
14 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 医疗研发外包 | 56.06 | 672.87 | 129.28 | 2.58 | — | 43.71 | 298.69% | 92.50% | 10.69% | 6.59% |
15 | 002821.SZ | 凯莱英 | 2016-11-25 | — | — | 医疗研发外包 | 109.96 | 41.78 | 37.15 | 2.32 | 1.0% | 396.51 | 23.71% | 15.83% | 18.20% | 10.10% |
16 | 688131.SH | 皓元医药 | 2023-09-25 | — | — | 医疗研发外包 | 70.41 | 74.08 | 52.78 | 5.06 | — | 149.34 | 115.55% | 272.28% | 24.20% | 20.05% |
17 | 300759.SZ | 康龙化成 | 2019-02-11 | — | — | 医疗研发外包 | 32.47 | 32.2 | 41.8 | 4.05 | 0.62% | 577.38 | -37.00% | 32.54% | 14.93% | 16.03% |
18 | 688046.SH | 药康生物 | 2023-09-25 | — | — | 医疗研发外包 | 18.36 | 68.55 | 72.11 | 3.47 | — | 75.28 | -7.12% | 1.70% | 10.11% | 8.76% |
19 | 300404.SZ | 博济医药 | 2015-05-04 | — | — | 医疗研发外包 | 10.75 | 144.03 | 291.65 | 4.09 | 0.11% | 41.45 | -48.33% | -76.38% | 5.88% | -17.06% |
20 | 300683.SZ | 海特生物 | 2024-07-31 | — | — | 医疗研发外包 | 40.26 | — | — | 2.24 | 0.32% | 52.70 | -72.10% | 15.81% | -3.36% | 18.79% |
21 | 688621.SH | 阳光诺和 | 2023-09-25 | — | — | 医疗研发外包 | 77.27 | 48.78 | 54.54 | 7.75 | — | 86.54 | -12.61% | -59.34% | 4.87% | -8.49% |
22 | 300725.SZ | 药石科技 | 2017-11-17 | — | — | 医疗研发外包 | 43.49 | 43.66 | 49.57 | 2.29 | 0.58% | 95.84 | -26.54% | -27.67% | 23.48% | 20.55% |
23 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 医疗研发外包 | 48.35 | 35.89 | 36.15 | 3.15 | 0.52% | 38.20 | -1.40% | -67.32% | -1.08% | -4.37% |
24 | 688073.SH | 毕得医药 | 2023-09-25 | — | — | 医疗研发外包 | 66.7 | 51.62 | 43.61 | 3.11 | — | 60.62 | 41.60% | 17.71% | 17.91% | 12.83% |
25 | 301230.SZ | 泓博医药 | 2022-11-08 | — | — | 医疗研发外包 | 36.91 | 301.59 | 199.17 | 5.08 | 1.15% | 51.52 | 54.99% | 226.47% | 32.73% | 29.61% |
26 | 603127.SH | 昭衍新药 | 2017-09-01 | — | — | 医疗研发外包 | 34.42 | 348.25 | 84.65 | 3.18 | 0.09% | 257.97 | 135.90% | 115.11% | -21.28% | -11.54% |
27 | 603259.SH | 药明康德 | 2018-05-15 | — | — | 医疗研发外包 | 104.65 | 32.68 | 22.43 | 4.69 | 1.29% | 3088.75 | 101.92% | 89.06% | 20.64% | 20.96% |
28 | 688222.SH | 成都先导 | 2023-09-25 | — | — | 医疗研发外包 | 25.63 | 199.96 | 112.6 | 7.19 | — | 102.69 | 390.72% | 102.90% | 16.58% | -0.60% |
免责声明:数据相关栏目所收集数据,均来自第三方个人或企业公开数据以及国家统计网站公开发布数据,数据由计算机技术自动收集更新再由作者校验,作者将尽力校验,但不能保证数据的完全准确。 阅读本栏目的用户必须明白,图表所示结果或标示仅供学习参考使用,均不构成交易依据。任何据此进行交易等行为,而引致的任何损害后果,本站概不负责。